润都股份发布前三季度业绩,归母净亏损5468.78万元
Rundu PharmaRundu Pharma(SZ:002923) 智通财经网·2025-10-30 15:00

Group 1 - The core viewpoint of the article is that Rundu Co., Ltd. (002923.SZ) reported its Q3 2025 results, showing a slight increase in revenue but a significant net loss [1] - For the first three quarters, the company achieved an operating income of 884 million yuan, representing a year-on-year growth of 0.85% [1] - The net loss attributable to shareholders of the listed company was 54.6878 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 66.1263 million yuan [1]